PeriplogeninCAS# 514-39-6 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 514-39-6 | SDF | Download SDF |
PubChem ID | 10574 | Appearance | Powder |
Formula | C23H34O5 | M.Wt | 390.51 |
Type of Compound | Steroids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 3-[(3S,5S,8R,9S,10R,13R,14S,17R)-3,5,14-trihydroxy-10,13-dimethyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | ||
SMILES | CC12CCC(CC1(CCC3C2CCC4(C3(CCC4C5=CC(=O)OC5)O)C)O)O | ||
Standard InChIKey | QJPCKAJTLHDNCS-FBAXFMHRSA-N | ||
Standard InChI | InChI=1S/C23H34O5/c1-20-7-3-15(24)12-22(20,26)9-5-18-17(20)4-8-21(2)16(6-10-23(18,21)27)14-11-19(25)28-13-14/h11,15-18,24,26-27H,3-10,12-13H2,1-2H3/t15-,16+,17-,18+,20+,21+,22-,23-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Periplogenin plays protective roles against thyrotoxicosis and associated cardiovascular problems, are mediated through its direct antithyroidal and/or LPO inhibiting properties. Periplogenin induces necroptotic cell death through oxidative stress in HaCaT cells and ameliorates skin lesions in the TPA- and IMQ-induced psoriasis-like mouse models. |
Targets | Sodium Channel | ATPase | Potassium Channel | ROS |
In vitro | Periplogenin induces necroptotic cell death through oxidative stress in HaCaT cells and ameliorates skin lesions in the TPA- and IMQ-induced psoriasis-like mouse models.[Pubmed: 26850986 ]Biochem Pharmacol. 2016 Apr 1;105:66-79.Psoriasis is a multifactorial skin disease that inconveniences many patients. Considering the side effects and drug resistance of the current therapy, it is urgent to discover more effective and safer anti-psoriatic drugs. |
In vivo | Periplogenin, isolated from Lagenaria siceraria, ameliorates L-T₄-induced hyperthyroidism and associated cardiovascular problems.[Pubmed: 21287437]Horm Metab Res. 2011 Mar;43(3):188-93.The importance of glycoside in the regulation of thyroid dysfunction is not well understood. |
Periplogenin Dilution Calculator
Periplogenin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.5608 mL | 12.8038 mL | 25.6075 mL | 51.2151 mL | 64.0188 mL |
5 mM | 0.5122 mL | 2.5608 mL | 5.1215 mL | 10.243 mL | 12.8038 mL |
10 mM | 0.2561 mL | 1.2804 mL | 2.5608 mL | 5.1215 mL | 6.4019 mL |
50 mM | 0.0512 mL | 0.2561 mL | 0.5122 mL | 1.0243 mL | 1.2804 mL |
100 mM | 0.0256 mL | 0.128 mL | 0.2561 mL | 0.5122 mL | 0.6402 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Abietic acid
Catalog No.:BCN2728
CAS No.:514-10-3
- Taraxerone
Catalog No.:BCN5636
CAS No.:514-07-8
- 2-(2-Aminoethyl)-1-methylpyrrolidine
Catalog No.:BCC8477
CAS No.:51387-90-7
- Boc-Methioninol
Catalog No.:BCC2720
CAS No.:51372-93-1
- Tris DBA
Catalog No.:BCC7685
CAS No.:51364-51-3
- delta-Amyrin acetate
Catalog No.:BCN5635
CAS No.:51361-60-5
- Budesonide
Catalog No.:BCC4767
CAS No.:51333-22-3
- Soyasaponin Bb
Catalog No.:BCN2598
CAS No.:51330-27-9
- Aloe-emodin-glucoside
Catalog No.:BCC8130
CAS No.:29010-56-8
- Tizanidine
Catalog No.:BCC4082
CAS No.:51322-75-9
- 27-Hydroxymangiferonic acid
Catalog No.:BCN4626
CAS No.:5132-66-1
- Alpha-Eudesmol
Catalog No.:BCC8272
CAS No.:473-16-5
- Parkeol
Catalog No.:BCN3728
CAS No.:514-45-4
- Tirucallol
Catalog No.:BCN7787
CAS No.:514-46-5
- Euphol
Catalog No.:BCN7790
CAS No.:514-47-6
- Ferruginol
Catalog No.:BCN3155
CAS No.:514-62-5
- Biperiden
Catalog No.:BCC4274
CAS No.:514-65-8
- Canthaxanthin
Catalog No.:BCC8139
CAS No.:514-78-3
- Alrestatin
Catalog No.:BCC6663
CAS No.:51411-04-2
- Chikusetsusaponin IVa
Catalog No.:BCN3432
CAS No.:51415-02-2
- Odonicin
Catalog No.:BCN5637
CAS No.:51419-51-3
- 3-Methyladenine
Catalog No.:BCC3714
CAS No.:5142-23-4
- COG 133
Catalog No.:BCC1047
CAS No.:514200-66-9
- Cyclo(Tyr-Phe)
Catalog No.:BCN2423
CAS No.:5147-17-1
Periplogenin, isolated from Lagenaria siceraria, ameliorates L-T(4)-induced hyperthyroidism and associated cardiovascular problems.[Pubmed:21287437]
Horm Metab Res. 2011 Mar;43(3):188-93.
The importance of glycoside in the regulation of thyroid dysfunction is not well understood. In the present investigation, effects of Periplogenin-3- O-D-glucopyranosyl (1-->6)(1-->4)-D-cymaropyranoside, isolated from the vegetable, LAGENARIA SICERARIA, in L-thyroxine (L-T(4))-induced hyperthyroidism and in related cardiovascular abnormalities have been revealed in Wistar albino rats. L-T(4) (500 mug/kg, s. c./d) administration for 12 days significantly increased serum concentrations of thyroxine (T(4)), triidothyronine (T(3)), and hepatic 5'-deiodinase I (5'-DI) activity with a parallel increase in lipid peroxidation (LPO) in different organs such as heart, liver and kidney; serum glucose and insulin concentrations and a decrease in cardiac Na (+)-K (+)-ATPase activity as well as serum total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, very low-density lipoprotein cholesterol and triglycerides. Most of these adverse effects were reversed following the administration of isolated Periplogenin. However, out of its 3 different concentrations (5.0, 10, and 25 mg/kg), 5 mg/kg appeared to be the most effective one as it could nearly normalize the level of T(3), glucose, insulin, Na (+)-K (+)-ATPase activity, tissue LPO and different serum lipids suggesting the protective role of Periplogenin against thyrotoxicosis and associated cardiovascular problems. It appears that the Periplogenin actions are mediated through its direct antithyroidal and/or LPO inhibiting properties.
Periplogenin induces necroptotic cell death through oxidative stress in HaCaT cells and ameliorates skin lesions in the TPA- and IMQ-induced psoriasis-like mouse models.[Pubmed:26850986]
Biochem Pharmacol. 2016 Apr 1;105:66-79.
Psoriasis is a multifactorial skin disease that inconveniences many patients. Considering the side effects and drug resistance of the current therapy, it is urgent to discover more effective and safer anti-psoriatic drugs. In the present study, we screened over 250 traditional Chinese medicine compounds for their ability to inhibit the cell viability of cultured human HaCaT keratinocytes, a psoriasis-relevant in vitro model, and found that Periplogenin was highly effective. Mechanistic studies revealed that apoptosis and autophagy were not induced by Periplogenin in HaCaT cells. However, Periplogenin caused PI to permeate into cells, increased lactate LDH release and rapidly increased the number of necrotic cells. Additionally, the typical characteristics of necrosis were observed in the Periplogenin-treated HaCaT cells. Notably, the necroptosis inhibitor Nec-1 and NSA were able to rescue the cells from necrotic cell death, supporting that necroptosis was involved in Periplogenin-induced cell death. Furthermore, the ROS levels were elevated in the Periplogenin-treated cells, NAC (an antioxidant) and Nec-1 could inhibit the ROS levels, and NAC could attenuate necroptotic cell death, indicating that the Periplogenin-induced necroptotic cell death was mediated by oxidative stress. More importantly, in the murine models of TPA-induced epidermal hyperplasia and IMQ-induced skin inflammation, topical administration of Periplogenin ameliorated skin lesions and inflammation. In sum, our results indicate, for the first time, that Periplogenin is a naturally occurring compound with potent anti-psoriatic effects in vitro and in vivo, making it a promising candidate for future drug research.